RecruitingNCT06904820

Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®


Sponsor

University Hospital, Limoges

Enrollment

2,300 participants

Start Date

Jun 5, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The "Scanvir" concept aims to achieve barriers to HCV screening and treating of marginalized patients. The concept is applicable to other various populations and territories and should effectively improve HCV patient's health outcomes. The main objective of the SCANVIR project was to evaluate the feasibility, acceptability and reproducibility of a "test, treat and cure" strategy for PWIDs and vulnerable populations during dedicated days in addiction care centers.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Adult 18 and over
  • Patient frequenting an unconventional structure "outside the walls" or referred by a professional in the care sector
  • Patient not opposed to research

Exclusion Criteria2

  • Age under 18
  • Patient opposed to research

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Limoges University Hospital

Limoges, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06904820


Related Trials